No abstract available
MeSH terms
-
Antineoplastic Combined Chemotherapy Protocols / adverse effects
-
Antineoplastic Combined Chemotherapy Protocols / therapeutic use*
-
Breast Neoplasms / chemistry
-
Breast Neoplasms / drug therapy*
-
Capecitabine
-
Clinical Trials, Phase II as Topic
-
Deoxycytidine / administration & dosage
-
Deoxycytidine / analogs & derivatives
-
Disclosure
-
Dose-Response Relationship, Drug
-
Drug Administration Schedule
-
Female
-
Fluorouracil / administration & dosage
-
Fluorouracil / analogs & derivatives
-
Humans
-
Lapatinib
-
Maximum Tolerated Dose
-
Quinazolines / administration & dosage
-
Receptor, ErbB-2 / analysis
Substances
-
Quinazolines
-
Lapatinib
-
Deoxycytidine
-
Capecitabine
-
ERBB2 protein, human
-
Receptor, ErbB-2
-
Fluorouracil